VRPX (Virpax Pharmaceuticals) Institutional Ownership: 0.02% (As of Jul. 07, 2026)


What is Virpax Pharmaceuticals Institutional Ownership?

Virpax Pharmaceuticals VRPX Institutional Ownership is 0.02% as of Jul. 07, 2026.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Virpax Pharmaceuticals's institutional ownership is 0.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Virpax Pharmaceuticals's Insider Ownership is 26.81%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Virpax Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 100.20%.

Virpax Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Virpax Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Virpax Pharmaceuticals Institutional Ownership Chart

Virpax Pharmaceuticals Historical Data

The historical data trend for Virpax Pharmaceuticals can be seen below:

2024-08-31 2024-09-30 2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31 2025-04-30 2025-05-31
Institutional Ownership 0.81 2.66 3.85 3.85 3.87 3.81 3.81 0.16 0.01 0.01

Virpax Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.02% mean?
Virpax Pharmaceuticals (VRPX) has a Institutional Ownership of 0.02% as of Jul. 07, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Virpax Pharmaceuticals and its competitors.
Is Virpax Pharmaceuticals' Institutional Ownership too high?
Virpax Pharmaceuticals' current Institutional Ownership is 0.02%.
How does Virpax Pharmaceuticals' Institutional Ownership compare to SYGGF and SCPX?
Virpax Pharmaceuticals' Institutional Ownership of 0.02% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Virpax Pharmaceuticals and its competitors. Virpax Pharmaceuticals's current Institutional Ownership is 0.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Virpax Pharmaceuticals stock overvalued right now?
Virpax Pharmaceuticals (VRPX) has a current Institutional Ownership of 0.02%. The current Institutional Ownership is 0.02%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Virpax Pharmaceuticals (VRPX), the current Institutional Ownership is 0.02% as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Virpax Pharmaceuticals Business Description

Address 1055 Westlakes Drive, Suite 300, Berwyn, PA, USA, 19312
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.